NCT02634970 CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab Status WITHDRAWN Phase PHASE4
NCT02632045 Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT02626377 Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté Status TERMINATED Phase NA
NCT02626234 A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02626221 A Worldwide Antihistamine-Refractory Chronic Urticaria Patient Evaluation in Latin America and Canada (AWARE-LACan) Status COMPLETED Phase N/A
NCT02625922 Study of the Effect of Serelaxin on High-sensitivity Cardiac Troponin I (Hs-cTnI) Release in Patients With Chronic Heart Failure Status TERMINATED Phase PHASE2
NCT02624570 Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy Status NO_LONGER_AVAILABLE Phase N/A
NCT02624557 Pharmacokinetic Study of Alpelisib in Subjects With Hepatic Impairment. Status COMPLETED Phase PHASE1
NCT02622581 Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients Status RECRUITING Phase N/A
NCT02619617 Safety and Efficacy Study of SOM230 s.c. in Cluster Headache Status TERMINATED Phase PHASE2
NCT02608268 Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT02607813 Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations Status TERMINATED Phase PHASE1
NCT02607774 Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis Status COMPLETED Phase PHASE1
NCT02605967 Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Status COMPLETED Phase PHASE2
NCT02603445 Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL Status COMPLETED Phase PHASE1
NCT02603393 Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD Status COMPLETED Phase PHASE4
NCT02601378 A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma. Status TERMINATED Phase PHASE1
NCT02598297 Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations. Status TERMINATED Phase PHASE3
NCT02596009 Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices Status COMPLETED Phase PHASE4
NCT02595970 Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis Status COMPLETED Phase PHASE3